Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Gets Abuse-Deterrent Claim on One Pain Drug, Then Drops Development of Another

Nov 03 2014

• By Laura Helbling

Related Content

Remoxy Development Not ‘Unmitigated Disaster,’ CEO Reassures; Hunt Begins For New Partner

Oct 28 2014

Getting Organized on Abuse-Deterrent Opioids: FDA Calls For Volunteers Ahead of Oct. 30-31 Meeting

Sep 11 2014

Seeking Guidance On Abuse-Deterrence: Sponsors Fall Short, Congress Urges Action

Jun 13 2014

King of Pain: Pfizer's Move into Abuse Resistant Opioids and the Virtues of Massive Scale

Nov 01 2010

The Best Bad Deal of All Time? Pfizer/King and the Business Dynamics of Abuse Deterrence

May 30 2013

Related Companies

Pfizer Inc.

King Pharmaceuticals, Inc.

Purdue Pharma L.P.

Cassava Sciences, Inc.

DURECT Corporation

Endo, Inc.

Mallinckrodt plc

Additional Topics

Regulation BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window